Cariporide is a selective sodium-hydrogen exchanger isoform 1 (NHE1) inhibitor primarily investigated for its cardioprotective effects in treating myocardial ischemia-reperfusion injury. By blocking the… Read more
Cariporide is a selective sodium-hydrogen exchanger isoform 1 (NHE1) inhibitor primarily investigated for its cardioprotective effects in treating myocardial ischemia-reperfusion injury. By blocking the NHE1 transporter, this compound helps regulate intracellular pH and prevents the detrimental accumulation of sodium and calcium ions within cardiac cells during ischemic events. Within the pharmaceutical and research sectors, this category encompasses essential compounds for rigorous analysis, including reference standards, degradation-related impurities, and metabolic products. These materials are critical for researchers conducting impurity profiling and method validation to ensure the precision and reliability of analytical procedures. Additionally, stable isotope labelled compounds are available to serve as high-quality internal standards in mass spectrometry-based assays, facilitating accurate quantification and pharmacokinetic studies. These comprehensive analytical tools support the ongoing evaluation of Cariporide in both clinical and preclinical pharmaceutical development.